No name

Did you know that schizophrenia affects more than 1 percent of the world's population? See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

Schizohrenia research & FAQs


Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

Brain & Behavior Research Foundation Outstanding Achievement Prizes
Outstanding Achievement Prizes
September 22, 2011

The Brain & Behavior Research Foundation will honor 8 extraordinary scientists with Outstanding Research Achievement Prizes for their accomplishments in brain and behavior research in New York City on October 26....

September 22, 2011

FOR IMMEDIATE RELEASE
Contact: Dianne Ackerman
E-mail: dackerman@bbrfoundation.org
Phone: (516) 829-0091

Scientists Honored For Outstanding Achievements in Mental Illness...

Stephanie Dulawa, Ph.D.
Stephanie Dulawa, Ph.D.
September 20, 2011

Currently, there is only one type of medication that has been shown to be effective in treating Obsessive-Compulsive Disorder (OCD). Serotonin Reuptake Inhibitors (SRIs), including clomipramine, have been shown to reduce...

Owen Whalen
Owen Whalen
September 16, 2011

This fall, 18-year-old Owen Whalen will enter the freshman class at Rochester Institute of Technology (RIT) in his home town of Rochester, New York. An outstanding student, he’s been awarded a tuition grant by the school...


September 15, 2011

NARSAD Independent Investigator Grantee Alan S. Brown, MD, MPH and colleagues discover that maternal immune system reaction to infection can affect brain development in the unborn child. This finding may alter medical...

Pages

Subscribe to